Additionally, a monomethyl auristatin E (MMAE)-conjugated CD73-ADC, known as Hu001-MMAE, protects T effector cells, activates DCs, exhibits cytotoxicity against tumor cells with high CD73 expression, and enhances the tumor immune response [314]. Here, NT5E is linked to neoplasm.